Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) had been explored extensively in patients affected by unresectable hepatocellular carcinoma. These agents were expected to be the keystones of the disease’s first-line treatment because they were theoretically able to revert the immune suppressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Salani, Francesca, Genovesi, Virginia, Vivaldi, Caterina, Massa, Valentina, Cesario, Silvia, Bernardini, Laura, Caccese, Miriam, Graziani, Jessica, Berra, Dario, Fornaro, Lorenzo, Masi, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563015/
https://www.ncbi.nlm.nih.gov/pubmed/36230819
http://dx.doi.org/10.3390/cancers14194896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563015/
https://www.ncbi.nlm.nih.gov/pubmed/36230819
http://dx.doi.org/10.3390/cancers14194896

Ejemplares similares